Trials / Recruiting
RecruitingNCT06773962
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease
A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of TB006 in Participants With Parkinson's Disease
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 62 (estimated)
- Sponsor
- TrueBinding, Inc. · Industry
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The primary objectives of this study are to assess the efficacy of TB006 in improving motor function and to assess the safety of TB006 in participants with Parkinson's Disease (PD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TB006 | IV infusion. |
| DRUG | Placebo | IV infusion. |
Timeline
- Start date
- 2025-03-20
- Primary completion
- 2026-03-01
- Completion
- 2026-09-01
- First posted
- 2025-01-14
- Last updated
- 2025-12-12
Locations
14 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06773962. Inclusion in this directory is not an endorsement.